Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study

2012/02/02 by Richard T. Scott, K.M. Ferry, Kathleen Ferry +4 · 29 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Prenatal Screening and Diagnostics #Reproductive Biology and Fertility #Genomic variations and chromosomal abnormalities

paper · doi:10.1016/j.fertnstert.2012.01.104

Cited by

• The use of preimplantation genetic testing for aneuploidy: a committee opinion
• On the reproductive capabilities of aneuploid human preimplantation embryos
• The evolution of preimplantation genetic testing: where is the limit?
• Investigating DNA contamination affecting embryo biopsy specimens taken for PGT-A: Incidence and impact on the accuracy of chromosomal analysis
• A review of, and commentary on, the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practice. [europepmc]
• Single thawed euploid embryo transfer improves IVF pregnancy, miscarriage, and multiple gestation outcomes and has similar implantation rates as egg donation. [europepmc]
• Could time-lapse embryo imaging reduce the need for biopsy and PGS? [europepmc]
• In vitro fertilization with preimplantation genetic screening improves implantation and live birth in women age 40 through 43. [europepmc]
• Assessment of aneuploidy formation in human blastocysts resulting from donated eggs and the necessity of the embryos for aneuploidy screening. [europepmc]
• Randomized comparison of next-generation sequencing and array comparative genomic hybridization for preimplantation genetic screening: a pilot study. [europepmc]
• The Impact of Biopsy on Human Embryo Developmental Potential during Preimplantation Genetic Diagnosis. [europepmc]
• Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences? [europepmc]
• A randomized and blinded comparison of qPCR and NGS-based detection of aneuploidy in a cell line mixture model of blastocyst biopsy mosaicism. [europepmc]
• Re-analysis of aneuploidy blastocysts with an inner cell mass and different regional trophectoderm cells. [europepmc]
• Association between growth dynamics, morphological parameters, the chromosomal status of the blastocysts, and clinical outcomes in IVF PGS cycles with single embryo transfer. [europepmc]
• Evaluation of comprehensive chromosome screening platforms for the detection of mosaic segmental aneuploidy. [europepmc]
• Optimal timing of blastocyst vitrification after trophectoderm biopsy for preimplantation genetic screening. [europepmc]
• Adrenomedullin improves fertility and promotes pinopodes and cell junctions in the peri-implantation endometrium. [europepmc]
• Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment. [europepmc]
• Preimplantation Genetic Testing for Aneuploidy Improves Clinical, Gestational, and Neonatal Outcomes in Advanced Maternal Age Patients Without Compromising Cumulative Live-Birth Rate. [europepmc]
• Utility and First Clinical Application of Screening Embryos for Polygenic Disease Risk Reduction. [europepmc]
• Diagnostic and therapeutic options in recurrent implantation failure. [europepmc]
• Preimplantation Genetic Testing for Chromosomal Abnormalities: Aneuploidy, Mosaicism, and Structural Rearrangements. [europepmc]
• Preimplantation Genetic Testing: Where We Are Today. [europepmc]
• Optimized NGS Approach for Detection of Aneuploidies and Mosaicism in PGT-A and Imbalances in PGT-SR. [europepmc]
• Healthy live births from transfer of low-mosaicism embryos after preimplantation genetic testing for aneuploidy. [europepmc]
• Preimplantation genetic testing for aneuploidy: A review of published blastocyst reanalysis concordance data. [europepmc]
• Defining recurrent implantation failure: a profusion of confusion or simply an illusion? [europepmc]
• Preimplantation genetic testing for aneuploidy: challenges in clinical practice. [europepmc]